Rheumatoid Arthritis - A Model of Systemic Inflammation Driving Atherosclerosis

被引：133
作者：
Ku, Ivy A. [1 ,2 ]
Imboden, John B. [3 ]
Hsue, Priscilla Y. [1 ,2 ]
Ganz, Peter [1 ,2 ]
机构：
[1] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA
[2] San Francisco Gen Hosp, Ctr Excellence Vasc Res, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, San Francisco Gen Hosp, Div Rheumatol, San Francisco, CA USA
来源：
CIRCULATION JOURNAL | 2009年 / 73卷 / 06期
关键词：
Atherosclerosis; Coronary artery disease; Inflammation; Rheumatoid arthritis; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL PROGENITOR CELLS; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; FACTOR-ALPHA THERAPY; CONVERTING ENZYME-INHIBITION; ACUTE MYOCARDIAL-INFARCTION; HIGH-DENSITY-LIPOPROTEIN; POPULATION-BASED COHORT;
D O I：
10.1253/circj.CJ-09-0274
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Similarities between the inflammatory pathways in atherosclerosis and rheumatoid arthritis (RA) are striking. Chronic systemic inflammation in RA patients leads to cardiovascular (CV) events beyond traditional cardiac risk factors. Clinicians typically focus on treating the joint manifestations of RA while neglecting to eliminate systemic inflammation, which leaves RA patients vulnerable to adverse CV events. In this review we provide an understanding of how systemic inflammation in RA accelerates atherosclerosis. This knowledge should guide therapeutic targets to minimize CV risk in RA, and may lead to insights into the inflammatory mechanisms of atherosclerosis in general. (Circ J 2009; 73: 977-985)
引用
收藏
页码：977 / 985
页数：9
相关论文
共 121 条
[1]   Effect of anti-TNFα treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis [J].
Ablin, Jacob N. ;
Boguslavski, Viktoria ;
Aloush, Valerie ;
Elkayam, Ori ;
Paran, Daphna ;
Caspi, Dan ;
George, Jacob .
LIFE SCIENCES, 2006, 79 (25) :2364-2369
[2]   Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease - A randomized trial [J].
Albert, Christine M. ;
Cook, Nancy R. ;
Gaziano, J. Michael ;
Zaharris, Elaine ;
MacFadyen, Jean ;
Danielson, Eleanor ;
Buring, Julie E. ;
Manson, JoAnn E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (17) :2027-2036
[3]  
Aubry MC, 2007, J RHEUMATOL, V34, P937
[4]   Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies [J].
Avina-Zubieta, J. Antonio ;
Choi, Hyon K. ;
Sadatsafavi, Mohsen ;
Etminan, Mahyar ;
Esdaile, John M. ;
Lacaille, Diane .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12) :1690-1697
[5]   Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis [J].
Baskol, G ;
Demir, H ;
Baskol, M ;
Kilic, E ;
Ates, F ;
Kocer, D ;
Muhtaroglu, S .
CLINICAL BIOCHEMISTRY, 2005, 38 (10) :951-955
[6]   Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study) [J].
Belcaro, G ;
Nicolaides, AN ;
Ramaswami, G ;
Cesarone, MR ;
De Sanctis, M ;
Incandela, L ;
Ferrari, P ;
Geroulakos, G ;
Barsotti, A ;
Griffin, M ;
Dhanjil, S ;
Sabetai, M ;
Bucci, M ;
Martines, G .
ATHEROSCLEROSIS, 2001, 156 (02) :379-387
[7]   Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis [J].
Bryl, E ;
Vallejo, AN ;
Matteson, EL ;
Witkowski, JM ;
Weyand, CM ;
Goronzy, JJ .
ARTHRITIS AND RHEUMATISM, 2005, 52 (10) :2996-3003
[8]  
Charles-Schoeman C, 2007, J RHEUMATOL, V34, P1459
[9]   Abnormal vitamin B6 status is associated with severity of symptoms in patients with rheumatoid arthritis [J].
Chiang, EPI ;
Bagley, PJ ;
Selhub, J ;
Nadeau, M ;
Roubenoff, R .
AMERICAN JOURNAL OF MEDICINE, 2003, 114 (04) :283-287
[10]   Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study [J].
Choi, HK ;
Hernán, MA ;
Seeger, JD ;
Robins, JM ;
Wolfe, F .
LANCET, 2002, 359 (9313) :1173-1177
12345678910